Skip to main content

and
  1. No Access

    Article

    S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer

    The development of resistance to EGFR Tyrosine kinase inhibitors (TKIs) in NSCLC with activating EGFR mutations is a critical limitation of this therapy. In addition to genetic alterations such as EGFR seconda...

    Hua Shen, Gao-Chan Wang, **ang Li, **n Ge, Meng Wang, Zhu-Mei Shi in Oncogene (2020)